We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEW BILLS TO COMPEL CLINICAL TRIAL REPORTING EYED
NEW BILLS TO COMPEL CLINICAL TRIAL REPORTING EYED
July 23, 2004
To compel greater compliance with posting requirements on clinical drug trial registries, two Democratic senators are giving consideration to authorizing the FDA to withhold approval of clinical trial protocols pending a sponsor's commitment to list on the registry.